Articles & Video
Simple Synthesis Method of Amidite Block
How the Right-Size Oligosynthesizer is Crucial to Manufacturing Productivity
Addressing Complex Oligonucleotide Therapeutics and Approach Towards Endotoxin Removal
Building an Oligo Manufacturing Partnership with Asahi Kasei Bioprocess and Axolabs
The PolyPeptide Group and OLIGO
RNA Leaders Europe
SCIENTIFIC, CLINICAL AND COMMERCIAL DEVELOPMENT OF RNA THERAPEUTICS AND VACCINES
TIDES USA: Oligonucleotide & Peptide Therapeutics
Industry’s Largest & Most Renowned Event to Accelerate Your Oligo and Peptide Therapeutics to Market: Leading Strategies for Expediting R&D and Improving CMC Efficiency.
DRIVING INNOVATION AND COMMERCIALISATION OF INDUCED-PROXIMITY DRUGS
There are many ways for your organisation to engage a qualified audience of 35,000+ TIDES executives and scientists, including 3,500+ annual attendees gathered across the globe! Share your strategy and plans so we can help you identify the best opportunities to reach your objectives. Our team will collaborate with you to develop a bespoke program tailored to your unique needs.
To find out more, contact:
Companies A, E-Z: Michael Moriarty, MMoriarty@informaconnectls.com
Companies B, C, D: Jennifer Wickett, JWickett@informaconnectls.com
Work with us to create a custom sponsorship program designed to meet your business objectives! Leverage a mix of in-person and digital opportunities to engage key decision makers all year long.
- Exhibition space
- Speaking slots and onsite video interviews
- High-impact branding and messaging
- Custom digital campaigns
- and more!